Dublin, June 22, 2020 (GLOBE NEWSWIRE) -- The "Global Psoriasis Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.
This report provides the most up-to-date information on key pipeline products in the global Psoriasis market. It covers emerging therapies for Psoriasis in active clinical development stages including early and late-stage clinical trials.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages: The report provides Psoriasis pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes: The report provides Psoriasis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company: The report provides Psoriasis pipeline products by the company.
Short-term Launch Highlights: Find out which Psoriasis pipeline products will be launched in the US and Ex-US till 2025.
Key Topics Covered
1. Psoriasis Pipeline by Stages
2. Psoriasis Phase 3 Clinical Trial Insights
3. Psoriasis Phase 2 Clinical Trial Insights
4. Psoriasis Phase 1 Clinical Trial Insights
5. Psoriasis Preclinical Research Insights
6. Psoriasis Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Psoriasis Phase 3 Clinical Trials, 2020
Table 2: Psoriasis Phase 2 Clinical Trials, 2020
Table 3: Psoriasis Phase 1 Clinical Trials, 2020
Table 4: Psoriasis Preclinical Research, 2020
Table 5: Psoriasis Discovery Stage, 2020
List of Figures
Figure 1: Psoriasis Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Psoriasis Phase 3 Clinical Trial Highlights, 2020
Figure 3: Psoriasis Phase 2 Clinical Trial Highlights, 2020
Figure 4: Psoriasis Phase 1 Clinical Trial Highlights, 2020
Figure 5: Psoriasis Preclinical Research Highlights, 2020
Figure 6: Psoriasis Discovery Stage Highlights, 2020
For more information about this report visit https://www.researchandmarkets.com/r/yno54r
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.